LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026)

LivaNova's (LIVN) quarterly Non-Current Deferred Tax Liability came in at $9.3 million in Q2 2026, down 18.28% year-over-year from $11.4 million in Q2 2025, and up 36.67% quarter-over-quarter from $6.8 million in Q1 2026.

Analysis

LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends

LivaNova has disclosed Non-Current Deferred Tax Liability across 12 years of filings, most recently posting $9.3 million for Q2 2026.

  • In Q2 2026, Non-Current Deferred Tax Liability fell 18.28% year-over-year to $9.3 million; the TTM figure through Jun 2026 stood at $9.3 million (down 18.28% YoY), while the FY2025 annual figure was $9.6 million, down 85.25% from the prior year.
  • Non-Current Deferred Tax Liability came in at $9.3 million for Q2 2026 at LivaNova, up from $6.8 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $89.2 million in Q4 2022 to a low of $6.5 million in Q3 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $19.9 million, with a median of $10.0 million recorded in 2023.
  • Year-over-year, Non-Current Deferred Tax Liability jumped 1054.62% in 2022 and slumped 85.25% in 2025.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $89.2 million in 2022, then sank by 30.34% to $62.2 million in 2023, then advanced by 4.62% to $65.0 million in 2024, then tumbled by 85.25% to $9.6 million in 2025, then dropped by 2.92% to $9.3 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $9.3 million in Q2 2026, $6.8 million in Q1 2026, and $9.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.31 Mn
Mar 31, 2026 6.81 Mn
Dec 31, 2025 9.59 Mn
Sep 30, 2025 10.10 Mn
Jun 30, 2025 11.39 Mn
Mar 31, 2025 10.63 Mn
Dec 31, 2024 65.03 Mn
Sep 30, 2024 11.84 Mn
Jun 30, 2024 10.84 Mn
Mar 31, 2024 10.97 Mn
Dec 31, 2023 62.16 Mn
Sep 30, 2023 9.93 Mn
Jun 30, 2023 8.92 Mn
Mar 31, 2023 8.63 Mn
Dec 31, 2022 89.23 Mn
Sep 30, 2022 6.53 Mn
Jun 30, 2022 7.66 Mn
Mar 31, 2022 7.88 Mn
Dec 31, 2021 7.73 Mn
Sep 30, 2021 8.31 Mn